We report the case of a term baby born to a diet controlled gestational diabetic mother with a birth weight of 2.8 kg. Baby was persistently hyperglycaemic from day 1 of life, leading to a diagnosis of neonatal diabetes being considered. She was breast-fed on demand and although insulin pump therapy was discussed, it was felt not to be suitable, as language barriers would have meant that parents would have had difficulty recognising pump failure/alarms. Twice daily subcutaneous injections of Isophane Insulin (Insulatard) were commenced, although there have been no studies on efficacy of Insulatard in neonates. The small doses of insulin required were administered by diluting the insulin with a suitable diluting medium. At 8 months of age our patient is thriving and developing well with no hospital admissions. She is on 0.2 units/kg/day of insulin with most recent glycosylated haemoglobin (HbA1C) being 48mmol/mol. No known genetic mutation has been identified.
